Apyx Medical Corporation Common Stock

APYXNASDAQUSD
3.11 USD
0.03 (0.97%)AT CLOSE (11:59 AM EDT)
3.17
0.06 (1.93%)
POST MARKET (AS OF 05:14 PM EDT)
Post Market
AS OF 05:14 PM EDT
3.17
0.06 (1.93%)
🟢Market: OPEN

Apyx Medical Corporation Common Stock (APYX) trades at $3.17 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place APYX at a fair price relative to peers.

Technical & fundamental data as of Aug 25, 2026.

Open?$3.12
High?$3.24
Low?$3.09
Prev. Close?$3.08
Volume?48.4K
Avg. Volume?102.2K
VWAP?$3.13
Rel. Volume?0.47x
Bid / Ask
Bid?$2.64 × 100
Ask?$3.71 × 100
Spread?$1.07
Midpoint?$3.18
Valuation & Ratios
Market Cap?129.7M
Shares Out?42.1M
Float?32.2M
Float %?76.6%
P/E Ratio?N/A
P/B Ratio?12.17
EPS?-$0.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
Employees
205
Market Cap
129.7M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1994-04-06
Address
5115 ULMERTON ROAD
CLEARWATER, FL 33760
Phone: (727) 384-2323
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
11
Momentum?
69
Short Sent.?
95
Piotroski F-Score?5/9Mixed
Altman Z-Score?1.02Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.71%Low
Short Interest?230.4K
Days to Cover?1.5
Free Float32.2M
Avg Daily Volume154.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?5.68Strong
Quick Ratio?4.53Strong
Cash Ratio?2.95Strong
Debt/Equity?3.32High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
16
12.17HIGH
P/S?
Peers
100
S&P
62
2.22CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-50.6CHEAP
EV/Sales?
Peers
100
S&P
70
2.35CHEAP
Returns & Efficiency
ROE?
S&P
3
-81.0%WEAK
ROA?
S&P
3
-14.1%WEAK
Cash Flow & Enterprise
FCF?$-11048000
Enterprise Value?$137.5M
Fundamentals ratios updated end of day